盐酸依他苯酮 | 2192-21-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 中文名称: 盐酸依他苯酮
• 英文名称: Relicor
• 英文别名: 1-[2-(2-diethylamino-ethoxy)-phenyl]-3-phenyl-propan-1-one; hydrochloride；1-[2-(2-Diaethylamino-aethoxy)-phenyl]-3-phenyl-propan-1-on; Hydrochlorid；2'-[2-(diethylamino)ethoxy]-3-phenylpropiophenone hydrochloride；2'-(2-diethylaminoethoxy)-dihydrochalcone hydrochloride；etafenone hydrochloride；1-[2-[2-(diethylamino)ethoxy]phenyl]-3-phenylpropan-1-one;hydron;chloride
• CAS: 2192-21-4
• 化学式: C₂₁H₂₇NO₂*ClH
• 分子量: 361.912
• InChiKey: BYWIEEUABBZFEE-UHFFFAOYSA-N

物化性质

• 熔点：
  129-130 °C

计算性质

• 辛醇/水分配系数(LogP)：
  4.64
• 重原子数：
  25
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2922509090

SDS

Version 1.2
Regulation (EC) No 1907/2006

---

1 - Product and Company Information

---

Product Name 2'-(2-DIETHYLAMINOETHOXY)-DIHYDROCHALCO&

---

2 - Hazards Identification

---

3 - Composition/Information on Ingredients

---

Product Name CAS # EC no Annex I
Index Number
2'-(2-DIETHYLAMINOETHOXY)-DIHYDROC 2192-21-4 218-587-9 None
HALCONEHYDROCHLORIDE
Formula C21H27NO2.ClH
Molecular Weight 361,8900 AMU
Synonyms Asamedol * Baxacor * Corodilan * Dialicor *
Dialicor hydrochloride *
1-(2-(2-(Diethylamino)ethoxy)phenyl)-3-phenyl-1-p
ropanone hydrochloride *
(O-beta-Diethylaminoethoxy)-phenyl propiophenone
hydrochloride * Etafenone hydrochloride * Etafon
hydrochloride * Hetaphenone * L.G. 11,457
hydrochloride * Pagano-cor *
beta-Phenyl-o-(diethylaminoethoxy)propiophenone
hydrochloride * 1-Propanone,
1-(2-(2-(diethylamino)ethoxy)phenyl)-3-phenyl-,
hydrochloride (9CI) * Relicor * Relicor
hydrochloride

---

4 - First Aid Measures

---

AFTER INHALATION
If inhaled, remove to fresh air. If not breathing give
artificial respiration. If breathing is difficult, give oxygen.
AFTER INGESTION
If swallowed, wash out mouth with water provided person is
conscious. Call a physician.

---

ALDRICH www.molbase.com
5 - Fire Fighting Measures

---

EXTINGUISHING MEDIA
Suitable: Water spray. Carbon dioxide, dry chemical powder, or
appropriate foam.
SPECIAL RISKS
Specific Hazard(s): Emits toxic fumes under fire conditions.
SPECIAL PROTECTIVE EQUIPMENT FOR FIREFIGHTERS
Wear self-contained breathing apparatus and protective clothing
to prevent contact with skin and eyes.

---

6 - Accidental Release Measures

---

PERSONAL PRECAUTION PROCEDURES TO BE FOLLOWED IN CASE OF LEAK OR SPILL
Evacuate area.
PROCEDURE(S) OF PERSONAL PRECAUTION(S)
Wear self-contained breathing apparatus, rubber boots, and heavy
rubber gloves.
METHODS FOR CLEANING UP
Sweep up, place in a bag and hold for waste disposal. Avoid
raising dust. Ventilate area and wash spill site after material
pickup is complete.

---

7 - Handling and Storage

---

HANDLING
Directions for Safe Handling: Do not breathe dust. Do not get in
eyes, on skin, on clothing. Avoid prolonged or repeated exposure.
STORAGE
Conditions of Storage: Keep tightly closed. Store in a cool dry
place.

---

8 - Exposure Controls / Personal Protection

---

ENGINEERING CONTROLS
Safety shower and eye bath. Use only in a chemical fume hood.
GENERAL HYGIENE MEASURES
Wash thoroughly after handling.
PERSONAL PROTECTIVE EQUIPMENT
Special Protective Measures: Wear appropriate government approved
respirator, chemical-resistant gloves, safety goggles, other
protective clothing.

---

9 - Physical and Chemical Properties

---

pH N/A
BP/BP Range N/A
MP/MP Range 129,000. - 130,000 °
C.
Flash Point N/A
Flammability N/A
Autoignition Temp N/A
Oxidizing Properties N/A
ALDRICH www.molbase.com
Explosive Properties N/A
Explosion Limits N/A
Vapor Pressure N/A
Partition Coefficient N/A
Viscosity N/A
Vapor Density N/A
Saturated Vapor Conc. N/A
Evaporation Rate N/A
Bulk Density N/A
Decomposition Temp. N/A
Solvent Content N/A
Water Content N/A
Surface Tension N/A
Conductivity N/A
Miscellaneous Data N/A
Solubility N/A

---

10 - Stability and Reactivity

---

STABILITY
Materials to Avoid: Strong oxidizing agents.
HAZARDOUS DECOMPOSITION PRODUCTS
Hazardous Decomposition Products: Carbon monoxide, Carbon dioxide,
Nitrogen oxides, Hydrogen chloride gas.

---

11 - Toxicological Information

---

RTECS NUMBER: UH0350000
ACUTE TOXICITY
LD50 LD50
Oral Oral
Rat Rat
716,000000 mg/kg 716,000000 mg/kg
Remarks: Behavioral:Convulsions or effect on seizure threshold.
Behavioral:Convulsions or effect on seizure threshold.
LD50 LD50
Intraperitoneal Intraperitoneal
Rat Rat
66 MG/KG 66 MG/KG
LD50 LD50
Subcutaneous Subcutaneous
Rat Rat
1900 MG/KG 1900 MG/KG
LD50 LD50
Intravenous Intravenous
Rat Rat
20800 UG/KG 20800 UG/KG
Remarks: Behavioral:Convulsions or effect on seizure threshold.
Behavioral:Convulsions or effect on seizure threshold.
LD50 LD50
Oral Oral
Mouse Mouse
352,000000 mg/kg 352,000000 mg/kg
ALDRICH www.molbase.com
LD50 LD50
Intraperitoneal Intraperitoneal
Mouse Mouse
90 MG/KG 90 MG/KG
LD50 LD50
Subcutaneous Subcutaneous
Mouse Mouse
234 MG/KG 234 MG/KG
LD50 LD50
Intravenous Intravenous
Mouse Mouse
28 MG/KG 28 MG/KG
LD50 LD50
Oral Oral
Dog Dog
50,000000 mg/kg 50,000000 mg/kg
Remarks: Behavioral:Convulsions or effect on seizure threshold.
Behavioral:Convulsions or effect on seizure threshold.
SIGNS AND SYMPTOMS OF EXPOSURE
To the best of our knowledge, the chemical, physical, and
toxicological properties have not been thoroughly investigated.
ROUTE OF EXPOSURE
Inhalation: Material is irritating to mucous membranes and upper
respiratory tract.
Multiple Routes: May be fatal if inhaled, swallowed, or absorbed
through skin. Causes eye and skin irritation.
TARGET ORGAN INFORMATION
Nerves. Heart.

---

12 - Ecological Information

---

No data available.

---

13 - Disposal Considerations

---

SUBSTANCE DISPOSAL
Dissolve or mix the material with a combustible solvent and burn
in a chemical incinerator equipped with an afterburner and
scrubber. Observe all federal, state, and local environmental
regulations.

---

14 - Transport Information

---

RID/ADR
Non-hazardous for road transport.
IMDG
Non-hazardous for sea transport.
IATA
Non-hazardous for air transport.

---

15 - Regulatory Information
ALDRICH www.molbase.com

---

COUNTRY SPECIFIC INFORMATION
Germany
WGK: 3
Self-Classification

---

16 - Other Information

---

WARRANTY
The above information is believed to be correct but does not
purport to be all inclusive and shall be used only as a guide. The
information in this document is based on the present state of our
knowledge and is applicable to the product with regard to
appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Inc.,
shall not be held liable for any damage resulting from handling or
from contact with the above product. See reverse side of invoice
or packing slip for additional terms and conditions of sale.
Copyright 2010 Co. License granted to make
unlimitedpaper copies for internal use only.
DISCLAIMER
For R&D use only. Not for drug, household or other uses.
ALDRICH www.molbase.com

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

文献信息

• [EN] CATALYTIC HYDROGENATION OF NITRILES TO PRODUCE CAPSAICINOID DERIVATIVES AND AMINE COMPOUNDS, AND METHODS FOR PURIFIYING AND OBTAINING THE POLYMORPHS THEREOF<br/>[FR] HYDROGENATION CATALYTIQUE DE NITRILES POUR PRODUIRE DES DERIVES CAPSAICINOIDES ET DES COMPOSES D'AMINES, ET PROCEDES DE PURIFICATION ET D'OBTENTION DE LEURS POLYMORPHES
  申请人：STIEFEL LABORATORIES

  公开号：WO2005068414A1

  公开（公告）日：2005-07-28

  Processes for preparing an amine compound by catalytically hydrogenating a precursor nitrile compound. In a particular aspect, the present hydrogenation process occurs in a dipolar organic solvent in the presence of a palladium/carbon catalyst and a strong anhydrous protic acid. In a further aspect, the preferred embodiment relates to a process for deprotecting a compound to produce an amine compound. In yet a further aspect, the preferred embodiment relates to amine products produced by the present processes. These amine products may be used for a variety of purposes.

  通过在存在钯/碳催化剂和强无水质子酸的情况下，在偶极有机溶剂中催化氢化前体腈化合物的过程。在一个特定方面，目前的氢化过程发生在一个偶极有机溶剂中，在钯/碳催化剂和强无水质子酸的存在下。在另一个方面，首选实施例涉及一种去保护化合物以产生胺化合物的过程。在另一个方面，首选实施例涉及通过目前的过程产生的胺产品。这些胺产品可以用于各种目的。
• Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof
  申请人：Meckler Harold

  公开号：US20060047171A1

  公开（公告）日：2006-03-02

  Processes for preparing an amine compound by catalytically hydrogenating a precursor nitrile compound. In a particular aspect, the present hydrogenation process occurs in a dipolar organic solvent in the presence of a palladium/carbon catalyst and a strong anhydrous protic acid. In a further aspect, the preferred embodiment relates to a process for deprotecting a compound to produce an amine compound. In yet a further aspect, the preferred embodiment relates to amine products produced by the present processes. These amine products may be used for a variety of purposes.

  通过催化氢化前体腈化合物制备胺化合物的过程。在特定方面，本氢化过程发生在极性有机溶剂中，在钯/碳催化剂和强无水质子酸的存在下。在进一步方面，首选实施例涉及去保护化合物以产生胺化合物的过程。在另一个进一步方面，首选实施例涉及由本过程产生的胺产品。这些胺产品可用于各种用途。
• Modified release formulations containing drug-ion exchange resin complexes
  申请人：Mehta Ketan

  公开号：US20070215511A1

  公开（公告）日：2007-09-20

  A coated drug-ion exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. The drug-ion exchange resin complex is in admixture with a release retardant. The coating is a polyvinyl acetate polymer and a plasticizer. Methods of making and products containing this coated complex are described.

  提供一种涂层药物-离子交换树脂复合物，包括由药物与药用可接受的离子交换树脂形成的核心。该药物-离子交换树脂复合物与释放延迟剂混合。涂层是聚乙烯醇聚合物和增塑剂。描述了制备方法和含有此涂层复合物的产品。
• Type II Cubic Liquid Crystal Composition
  申请人：Hatoh Masakatsu

  公开号：US20080113923A1

  公开（公告）日：2008-05-15

  A cubic liquid crystal composition comprising at least one amphiphilic compound having the following general formula (1) and having an IV/OV value of 0.65 to 0.95, and water or an aqueous medium: wherein R represents a hydrophilic group; X and Y each independently represent a hydrogen atom or together form an oxygen atom; n is an integer of 0 to 4; and m is an integer of 0 to 3.

  一种立方液晶组合物，包括至少一种具有以下通式（1）并具有0.65至0.95的IV/OV值的两性化合物和水或水性介质：其中R代表亲水基团；X和Y各自独立地表示氢原子或一起形成氧原子；n为0至4的整数；m为0至3的整数。
• Novel benzothiazepine and bensothiepine compounds
  申请人：Sasahara Takehiko

  公开号：US20070190041A1

  公开（公告）日：2007-08-16

  A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substitutent:

  提供了一种药物，可用作治疗和预防高脂血症的治疗剂和预防剂，以及一种药物，可用作治疗和预防与胆汁淤积有关的肝脏疾病，特别是原发性胆汁性肝硬化和原发性硬化性胆管炎的治疗剂和预防剂，以及一种药物，可用作治疗和预防肥胖症、脂肪肝和脂肪性肝炎的治疗剂和预防剂。化合物的苯并噻吩或苯并噻环代表如下式（1A），具有硫酰胺键和季铵取代基：